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AbstrAct
Objective To assess the associations between ambient 
temperatures and hospitalisations for coronary heart 
disease (CHD) and stroke.
Methods Our study comprised all residents living in 
Ontario, Canada, 1996–2013. For each of 14 health 
regions, we fitted a distributed lag non-linear model to 
estimate the cold and heat effects on hospitalisations 
from CHD, acute myocardial infarction (AMI), stroke 
and ischaemic stroke, respectively. These effects 
were pooled using a multivariate meta-analysis. We 
computed attributable hospitalisations for cold and 
heat, defined as temperatures above and below the 
optimum temperature (corresponding to the temperature 
of minimum morbidity) and for moderate and extreme 
temperatures, defined using cut-offs at the 2.5th and 
97.5th temperature percentiles.
results Between 1996 and 2013, we identified 
1.4 million hospitalisations from CHD and 355 837 
from stroke across Ontario. On cold days with 
temperature corresponding to the 1st percentile of 
temperature distribution, we found a 9% increase in 
daily hospitalisations for CHD (95% CI 1% to 16%), 
29% increase for AMI (95% CI 15% to 45%) and 11% 
increase for stroke (95% CI 1% to 22%) relative to days 
with an optimal temperature. High temperatures (the 
99th percentile) also increased CHD hospitalisations 
by 6% (95% CI 1% to 11%) relative to the optimal 
temperature. These estimates translate into 2.49% of 
CHD hospitalisations attributable to cold and 1.20% 
from heat. Additionally, 1.71% of stroke hospitalisations 
were attributable to cold. Importantly, moderate 
temperatures, rather than extreme temperatures, 
yielded the most of the cardiovascular burdens from 
temperatures.
conclusions Ambient temperatures, especially in 
moderate ranges, may be an important risk factor for 
cardiovascular-related hospitalisations.
IntrOductIOn 
There is unequivocal evidence that short-term expo-
sure to low and high ambient temperatures increases 
cardiovascular mortality.1 There are also growing 
experimental studies showing that exposure to 
ambient temperature, especially cold, induces the 
change in blood pressure, vasoconstriction and 
increases blood viscosity and plasma fibrinogen, 
which can potentially lead to adverse cardiovas-
cular events.2 3 However, epidemiological research 
quantifying the temperature-related burden of 
cardiovascular morbidity, especially major cardio-
vascular diseases (ie, coronary heart disease (CHD) 
and stroke), is sparse.4 Even less is known who are 
most susceptible for cardiovascular-related hospital 
admissions on cold and hot days.
The relationship of temperatures with cardio-
vascular-related mortality and morbidity has been 
investigated in several previous studies that predom-
inantly focused on extreme temperatures (eg, cold 
spells and heat waves).1 4 Recently, a large study 
involving 13 countries reported that temperatures 
in a moderate range were responsible for far more 
deaths than were extreme cold and heat.5 However, 
whether exposure to moderate temperatures also 
contributes to more cardiovascular morbidity than 
extremes remains unknown. This is particularly 
relevant given the enormous burden of cardiovas-
cular morbidity on public health.
Heart disease and stroke affect ~27.6 million 
people in the USA.6 In Canada, an estimated 
1.6 million individuals are living with heart disease 
or long-term stroke disability.7 Considering the 
high prevalence of these conditions and that climate 
change is increasing variability of both low and high 
temperatures,8 we conducted a population-based 
study to estimate the associations between tempera-
tures and hospitalisations for CHD and stroke in 
Ontario, Canada. Additionally, we quantified the 
burden of hospitalisations from CHD and stroke 
attributable to cold and heat, separated into 
moderate and extreme ranges.
MethOds
study population and outcomes
The study population comprised all Ontario resi-
dents who were admitted to a hospital in Ontario 
from 1 January 1996 to 31 December 2013 with 
a primary or most responsible diagnosis of CHD, 
acute myocardial infarction (AMI), stroke or 
ischaemic stroke (International Classification of 
Diseases 9th and 10th diagnosis codes are listed in 
online supplementary table S1). We obtained the 
hospitalisation data from the Hospital Discharge 
Abstract Database of the Canadian Institute of 
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medicare system for hospital, laboratory and physician services 
that covers virtually the entire population (~13 million people).9
The healthcare system of Ontario is organised into 14 health 
regions (known as Local Health Integration Networks) that are 
responsible for planning, integrating and funding various local 
healthcare services. We obtained daily number of hospitalisa-
tions for the four selected outcomes in each health region, using 
information from the Registered Persons Database, a registry of 
all Ontario residents who have ever had a valid health card. Data 
linkage was performed through individuals’ unique encrypted 
health card numbers.
The Research Ethics Board of the University of Toronto 
approved the study (protocol reference 28527).
temperature data
We obtained hourly air temperatures (°C) during the study 
period at 125 monitoring stations across Ontario from Envi-
ronment Canada (online supplementary table S2).10 We calcu-
lated daily mean, maximum and minimum temperature for each 
weather station, and then averaged daily data across all weather 
stations within each region. We a priori selected mean tempera-
ture as the primary exposure, as it captures temperature expo-
sure throughout the entire day and night.11
Potential confounders and effect modifiers
We obtained hourly measurements of relative humidity and 
major air pollutants including nitrogen dioxide (NO2), ozone 
(O3) and fine particulate matter (<2.5 µm in aerodynamic diam-
eter (PM2.5)) from all monitoring stations across Ontario during 
the study period, from which we derived daily average estimates 
of these measures for each health region. Because of substantial 
missingness before 2003, we were unable to include PM2.5 in 
main analysis but considered it in a sensitivity analysis. We also 
derived the daily number of physician office visits due to influ-
enza in each health region using data from the Ontario Health 
Insurance Plan Claims Database. Furthermore, we created indi-
cator variables for holidays and the day of week.
To identify potential factors that may increase individual’s 
susceptibility to the effect of temperature on cardiovascular 
hospitalisations, we obtained information on age, sex, whether 
a patient was hospitalised for CHD or stroke for the first time 
or not, selected comorbid conditions (ie, AMI, cardiac dysrhyth-
mias, congestive heart diseases, diabetes and hypertensive 
diseases) and medication use (ie, statin, anticoagulants, all types 
of antihypertensive drugs, ACE inhibitors and beta blockers) (see 
online supplementary materials).
statistical analysis
To estimate the associations between daily mean temperatures 
and hospitalisations, we conducted a two-stage analysis. In the 
first stage, we used the distributed lag non-linear model combined 
with a quasi-Poisson regression to examine the non-linear and 
lag effects of mean temperature on hospitalisation in each health 
region.12 This analysis was conducted for each condition sepa-
rately. In all models, we controlled for relative humidity, NO2, 
O3, a day-of-week indicator, holiday status, daily influenza visits, 
as well as seasonality and long-term trends using a natural cubic 
spline with 7 df per year for time.13 To characterise the tempera-
ture–hospitalisation relationship, we used natural cubic spline 
for temperature (with 4 df, including three internal knots at 
the 10th, 50th and 90th percentiles of region-specific tempera-
tures) and natural cubic for lags (3 df).5 This choice of model 
specification resulted in a better fit than the other model forms 
that we also examined, according to Akaike’s Information Crite-
rion for quasi-Poisson (online supplementary table S3). To fully 
capture the overall temperature effects and adjust for a possible 
harvesting effect, we used a 21-day lag in all models.5
In the second stage of the analyses, we pooled the region-
level estimates using a multivariate meta-analysis to derive a 
summary estimate across Ontario.14 Similar to previous studies,5 
we identified the temperature corresponding to the lowest risk 
at the pooled temperature–hospitalisation curve as the optimal 
temperature and the reference value.5 We then obtained esti-
mates for the cold and heat effects on CHD and stroke hospital-
isations (see online supplementary materials).
To examine the robustness of our effect estimates, we 
conducted a series of sensitivity analyses including changing the 
df for temperature from 4 to 5 and the internal knot for lag from 
1 to 2 and reducing the lag period from 21 days to 14 days. 
We also adjusted daily concentration of PM2.5 in a subset of the 
population.
Additionally, we examined whether a subpopulation may 
be more susceptible for hospitalisations from CHD and stroke 
due to heat and cold exposure by conducting subgroup anal-
yses by age (<65 vs ≥65 years), sex, first-time hospitalisations 
or not, any history of selected comorbidities and the intake of 
selected medications. We assessed the statistical significance of 
effect modification by testing whether the interaction between 
temperature and selected individual characteristics was statisti-
cally significant.
Furthermore, we estimated fractions and numbers of hospi-
talisations for CHD and stroke attributable to cold and heat, 
defined as temperatures above and below the optimum tempera-
ture and for moderate and extreme temperatures, defined using 
cut-offs at the 2.5th and 97.5th temperature percentiles5 (see 
online supplementary figure S1 and table S2 for these definitions 
and the actual temperature ranges corresponding to extreme/
moderate temperatures in each health region).
Statistical analyses were conducted using the R software 
(V.3.0.3) with the ‘dlnm’ and ‘mvmeta’ packages.
results
study population
Between 1996 and 2013, we identified a total of 1 389 057 CHD 
hospitalisations CHD, of which 443 447 (31.9%) were from 
AMI and 355 837 from stroke admissions, of which 237 979 
(66.9%) from ischaemic stroke across Ontario, Canada (table 1). 
During the study period, the minimum and maximum daily 
mean temperatures across health regions in Ontario ranged from 
−33.1°C to 32.2°C (online supplementary table S2). The mean 
temperatures in Ontario varied with season (see online supple-
mentary figure S2 for the full data series for mean temperatures).
Association between temperature and hospitalisation
Figure 1 shows overall cumulative exposure–response relation-
ships between daily hospitalisations for the four conditions and 
mean temperatures across a 21-day lag period in Ontario. For 
CHD, stroke and ischaemic stroke, we observed U-shaped asso-
ciations with temperatures, with higher risks of hospitalisations 
at both extreme low and high temperatures. For AMI, there 
was a reverse J-shaped relationship, with a greater effect at low 
temperatures. We note that the optimal temperature for AMI 
(at the 94th percentile) was somewhat higher than those for 
CHD (79th), stroke (74th) and ischaemic stroke (76th) (table 2). 
We observed that the exposure–response relationship exhib-
ited similar patterns across the 14 health regions (see online 
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supplementary figure S3 and S4 for exposure–response curves in 
four selected health regions).
Compared with days with the optimal temperature, cold days 
with temperature corresponding to the 1st percentile of tempera-
tures were associated with significant increases in hospitalisations 
from CHD (relative risk (RR): 1.09; 95% CI 1.01 to 1.16), AMI 
(RR: 1.29; 95% CI 1.15 to 1.45) and stroke (RR: 1.11; 95% CI 
1.01 to 1.22) (table 2). These effects remained elevated even 
comparing with the days with temperature corresponding to 
the 25th percentile of temperatures. For ischaemic stroke, we 
table 1 Descriptive statistics of study population in Ontario, Canada, 1996–2013
characteristics
cardiovascular-related hospitalisations
chd AMI stroke Ischaemic stroke
n=1 389 057 n=443 447 n=355 837 n=237 979
Demographic characteristics
  Age, mean (IQR), year 66.5 (64–82) 68.5 (58–80) 71.0 (64–82) 73.0 (66–83)
  Men 65.9 63.2 50.8 50.4
First-time hospitalisation* (%) 37.7 70.2 72.6 78.9
Comorbidity† (%)
  AMI 26.3 24.4 6.2 6.8
  Cardiac dysrhythmias 13.8 12.2 14.6 16.0
  Congestive heart failure 13.4 14.6 9.4 10.7
  Diabetes 21.6 19.8 16.8 18.4
  Hypertensive disease 30.7 25.8 27.4 28.6
Medication‡ (%)
  Statin 45.9 33.3 27.0 25.6
  Antihypertensive medication§ 79.1 68.7 62.4 63.5
   ACE inhibitors 41.2 36.8 33.0 33.3
   Beta blockers 48.1 35.4 28.4 29.4
  Oral anticoagulants 9.3 8.9 11.7 11.0
*Defined as whether a patient was hospitalised for the first time for each condition.
†Ascertained using the records of hospitalisations from the selected conditions (based on all diagnostic codes) within 5 years before the hospitalisations under investigation.
‡Prescribed within 90 days prior to hospitalisations. The medication data were only available for subjects aged 65 years and above.
§Includes ACE inhibitors, angiotensin receptor blockers, beta blockers and calcium chann.
AMI, acute myocardial infarction; CHD, coronary heart disease.
Figure 1 Cumulative exposure–response associations of daily mean temperatures and hospitalisations for (A) coronary heart disease, (B) acute 
myocardial infraction, (C) stroke and (D) ischaemic stroke over a lag of 21 days in Ontario, Canada, 1996–2013. These associations were pooled across 
estimates in 14 health regions.
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found a positive (although non-significant) association with 
cold temperatures. In contrast, hot daily temperatures (the 99th 
percentile) was associated with a 6% (95% CI 1% to 11%) 
increase in hospitalisations for CHD compared with either the 
optimal temperature or the 75th percentile of temperature. Hot 
temperatures were also positively associated with hospitalisa-
tions from stroke (RR: 1.08; 95% CI 0.99 to 1.17) and isch-
aemic stroke (RR: 1.12; 95% CI 0.97 to 1.18). There was little 
evidence linking heat to AMI.
temperature-related burden of hospitalisations
Cold temperatures were estimated to put forward 2.49% (95% 
CI 1.03% to 3.67%) of hospitalisations from CHD (or 34 456 
admissions), while heat exposure gave rise to 1.20% (95% CI 
0.22% to 2.14%) CHD admissions (or 16 628) (table 3). For 
stroke, cold temperatures were contributed to 1.71% (95% 
CI 0.77% to 2.64%) of hospitalisations (or 6051 admissions) 
and hot temperatures contributed to 1.82% (95% CI 0.06% to 
3.21%) of hospitalisations (or 6469 admissions).
Further separating the burden into components related to 
moderate and extreme temperatures, we found that most of the 
hospitalisations for CHD and stroke were attributed to cold and 
hot temperature in the moderate ranges. Conversely, extreme 
cold and hot temperatures were attributable to a small fraction 
of the burden of these hospitalisations (ranging from 0.16% to 
0.29%, depending on the outcomes).
stratified and sensitivity analyses
We found that elderly people who regularly took oral anticoag-
ulants had a 48% higher risk for stroke admissions on hot days 
(95% CI 1.11 to 1.97) than non-users (RR: 0.99, 95% CI 0.89 to 
1.10) (pinteraction=0.01) (figures 2 and 3).
Sensitivity analyses showed that our estimates were robust to 
the change of df for temperature from 4 to 5 and the change 
of the internal knot for lag from 1 to 2 (online supplementary 
table S4). Cumulative exposure–response associations over a lag 
of 14 days exhibited similar patterns but somewhat attenuated 
estimates of both cold and heat effects as compared with those 
over a lag of 21 days (online supplementary figure S5). Further 
adjusting for PM2.5 in a subpopulation with complete pollution 
data did not materially change the estimates (online supplemen-
tary table S5).
dIscussIOn
In this large population-based cohort in Ontario, we found that 
short-term exposure to cold temperatures significantly increased 
the daily rates of hospitalisations for CHD, AMI and stroke. 
High temperatures were associated to a lesser degree with the 
hospitalisations for these conditions. Overall, we estimated 
that ~3.7% of CHD hospitalisations (51 084 admissions) and 
3.5% of stroke hospitalisations (12 520 admissions) in this popu-
lation were brought forward by temperature exposures, which 
would be associated with approximately C$40 million medical 
costs per year (see online supplementary material). Importantly, 
most of these hospitalisations were attributable to moderate 
temperatures, rather than temperature extremes. To our knowl-
edge, this is the first study that reported the significant cardio-
vascular burden from both low and high temperatures.
We found increased risks of CHD hospitalisations with both 
cold and hot temperatures in Ontario. This finding is supported 
table 2 Cumulative relative risks (RRs) and 95% CIs for cold and heat effects on daily hospitalisations for coronary heart disease (CHD), acute 
myocardial infarction (AMI), stroke and ischaemic stroke over a lag of 21 days in Ontario, Canada, 1996–2013
cardiovascular-related 
hospitalisations
Percentile of the optimal 
temperature*
cold effect† heat effect‡
rr (95% cI) rr (95% cI)
1st versus 25th
1st versus optimal 
temperature 99th versus 75th
99th versus optimal 
temperature
CHD 79 1.06 (1.01 to 1.10) 1.09 (1.01–1.16) 1.06 (1.01 to 1.11) 1.06 (1.01–1.11)
AMI 94 1.09 (1.03 to 1.16) 1.29 (1.15–1.45) 0.99 (0.92 to 1.06) 1.01 (0.96–1.05)
Stroke 74 1.09 (1.01 to 1.18) 1.11 (1.01–1.22) 1.08 (0.99 to 1.17) 1.08 (0.99–1.17)
Ischaemic stroke 76 1.06 (0.96 to 1.17) 1.12 (0.97–1.28) 1.07 (0.96 to 1.19) 1.12 (0.97–1.18)
*The temperature corresponding to the lowest risk from the pooled Ontario-wide temperature-hospitalisation curve.
†RRs associated with the 1st percentile of temperature distribution relative to the 25th percentile and the optimal temperature, respectively.
‡RRs associated with the 99th percentile of temperature distribution relative to the 75th percentile and the optimal temperature, respectively.
table 3 Estimated attributable fractions (%), attributable numbers and 95% CIs for cumulative cold and heat effects on daily hospitalisations for 
coronary heart disease (CHD) and stroke over a lag of 21 days in Ontario, Canada, 1996–2013
temperature range
chd stroke
Attributable fractions (%) 
(95% cI) Attributable number (95% cI)
Attributable fractions (%) 
(95% cI) Attributable number (95% cI)
Total cold* 2.49 (1.03 to 3.67) 34 456 (14 244 to 50758) 1.71 (0.77 to 2.64) 6051 (2744 to 9361)
Extreme cold† 0.23 (0.14 to 0.29) 3119 (1969 to 4072) 0.29 (0.21 to 0.36) 1038 (752 to 1277)
Moderate cold‡ 2.27 (0.88 to 3.47) 31 351 (12 152 to 47 993) 1.42 (0.38 to 2.33) 5019 (1336 to 8261)
Total heat* 1.20 (0.22 to 2.14) 16 628 (3040 to 29 559) 1.82 (0.06 to 3.21) 6469 (223 to 11 378)
Extreme heat† 0.16 (0.09 to 0.22) 2176 (1216 to 3093) 0.19 (0.11 to 0.26) 680 (401 to 921)
Moderate heat‡ 1.05 (0.07 to 1.87) 14 472 (929 to 25 823) 1.63 (−0.06 to 3.10) 5795 (−204 to 10 986)
*Total cold and heat were defined as temperatures lower and higher than the optimum temperature.
†Extreme cold was defined as temperatures lower than the 2.5th percentile, while extreme heat was defined as temperatures higher than the 97.5th percentile.
‡Moderate cold was defined as temperatures in the range between the optimal temperature and the 2.5th percentile, while moderate heat was defined as temperatures in the 
range between the optimum temperature and the 97.5th percentile.
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by a handful of previous studies conducted in regions with 
different climate conditions (eg, the USA,15 16 Hong Kong,17 
Australia18 and Spain18) that reported either the cold17 18 or 
heat15 16 effects on CHD morbidity. Similarly, we observed 
tendency towards increasing stroke-related hospitalisations in 
response to both low and high temperatures. Few studies so far 
have assessed both cold and heat effects on stroke morbidity.19 
Our findings may have important implications. First, climate 
change will bring more hot days and likely intensify the effects of 
the jet stream’s position, causing more severe cold winters.8 Our 
results indicate that temperature-related cardiovascular hospi-
talisations could persist under future climate change scenarios 
unless preventive efforts are made. It would be beneficial to 
expand public education and awareness campaigns on reducing 
traditional lifestyle-related risk factors to further consider envi-
ronmental factors, such as low and high temperatures. Second, 
because approximately 62% CHD admissions and 27% stroke 
admissions were recurrent hospitalisations in this study, inpatient 
education regarding preventive behavioural change on cold/hot 
days (eg, maintaining optimal indoor temperatures and wearing 
proper clothes)20 could be an asset in reducing temperature-re-
lated readmissions and related healthcare costs. Third, we found 
that risks of hospitalisations for CHD and stroke could remain 
elevated for 21 days after exposure to cold/heat, indicating that 
there is an opportunity to implement interventions and clinical 
treatments during this critical time window.
We found heightened risk for AMI hospitalisation in associa-
tion with cold but not high temperatures, which is consistent with 
a handful of previous studies suggesting that increased risk for 
AMI may be exclusively associated with cold temperature.21–23 
This variation may be due to different physiological processes of 
different cardiovascular conditions in response to cold and heat. 
Figure 2 Cumulative cold and heat effects on hospitalisations for coronary heart disease by selected individual characteristics over 21 lag days 
in Ontario, Canada, 1996–2013. Cold and heat effects were examined by calculating relative risks associated with the 1st percentile of temperature 
relative to the 25th percentile and the 99th percentile relative to the 75th percentile, respectively. The subgroup analyses of medication intake were 
restricted to subjects aged 65 years and over.
Figure 3 Cumulative cold and heat effects on hospitalisations for stroke by selected individual characteristics over 21 lag days in Ontario, Canada, 
1996–2013. Cold and heat effects were examined by calculating relative risks associated with the 1st percentile of temperature relative to the 25th 
percentile and the 99th percentile relative to the 75th percentile, respectively. The subgroup analyses of medication intake were restricted to subjects 
aged 65 years and over.
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This finding indicates the importance of understanding the spec-
ificity of temperature-related health effects, which may facilitate 
better targeting of health resources and interventions.
To date, most studies examining the health effects of high 
and low temperatures have focused on the effects of extreme 
temperatures,4 with less attention to evaluate the impact of 
moderate temperatures. However, in a recent multicountry 
study involving more than 74 million deaths, Gasparrini and 
colleagues reported that in all 13 study countries, most of 
the temperature-related mortality burden was attributable to 
moderate temperatures (with an overall estimate of 6.8%) rather 
than extreme temperatures (0.9%), although the optimum 
temperature varied from the 60th percentile in tropical countries 
to about the 90th percentile in cold regions.5 Our study extends 
the mortality study by further showing that moderate tempera-
tures posed a greater impact on increasing the burden of cardio-
vascular hospitalisations than that from extreme temperatures. 
Taken together, these observations suggest that the variations 
in temperatures play a major role in temperature-related health 
risk and that our study results can be highly relevant to regions 
of the world with different weather and temperature variation. 
An important implication of these findings is that clinical and 
public health interventions aiming to reduce adverse cardiovas-
cular events due to exposure to extreme weather could benefit 
from further considering the whole range of temperature effects 
in both moderate and extreme ranges.
We observed that the elderly who regularly took oral antico-
agulants exhibited a significantly increased risk for stroke admis-
sions on hot days than non-users. While oral anticoagulants 
(eg, heparin and warfarin) have been widely used to eliminate 
or reduce the risk of blood clots, this type of medication can 
also cause bleeding problems, which may result in an elevated 
risk of haemorrhagic stroke caused by a burst or bleeding blood 
vessel.24 This finding underscores the importance for clinicians 
and public health professionals to consider potential suscepti-
bility factors for the temperature–health effect when preventing 
and treating major cardiovascular diseases.
There are several biological mechanisms through which 
exposure to ambient temperatures can affect the cardiovascular 
system. Cold exposure are known to increase in blood pressure, 
heart rate, plasma fibrinogen, platelet viscosity and peripheral 
vasoconstriction.25 Cold may also increase cardiac load through 
raised inflammatory markers and coagulation parameters.26 
Additionally, cold temperatures may trigger higher haemoglobin 
A1c levels in people with type 2 diabetes, which is a major risk 
factor for cardiovascular disease.27 Similarly, exposure to heat can 
elevate heart rate, blood pressure, blood viscosity and coagula-
bility, weaken core temperature regulation and heighten the risk 
of coronary events and stroke.28 As well, dehydration after heat 
exposure can lead to fluid and electrolyte disturbances that are 
a frequent complication in patients with coronary dysfunction.4
The main strength of this study is its focus on the entire 
population of Ontario, the most populous province in Canada, 
rather than selected cities. Our analysis was based on a large 
cohort with ~1.7 million hospitalisations over 17 years. Addi-
tionally, the application of a recently developed multivariate 
meta-analytical model14 also allowed us to pool the delayed 
and non-linear temperature–hospitalisation relationships across 
Ontario. Furthermore, our analysis controlled for various poten-
tial confounders, including relative humidity, air pollution, influ-
enza activity, seasonality and long-term trend and so on. These 
variables have been seldom considered in previous study inves-
tigating the short-term health effects of temperatures.1 4 As well, 
we collected detailed information on major comorbid conditions 
and the use of medications using validated databases, providing 
an opportunity to evaluate potential effect modification by 
these characteristics. Little is known about the potential roles 
of comorbidities and medications in temperature–hospitalisation 
associations.
This study has several limitations. First, our analysis was 
restricted to people admitted to hospital. Our results, therefore, 
could not capture the effects of temperature on the coronary and 
stroke events in the outpatient settings (eg, emergency depart-
ment visits), which may be more acute but not severe enough for 
hospitalisations. Second, similar to previous studies on tempera-
ture and hospitalisation,4 we considered only primary diagnosis 
as main reason for hospitalisation. Although this improved the 
accuracy in ascertaining cardiovascular hospitalisations, it might 
also have led to some underestimation of the burden on hospital-
isations. A further limitation is the possible exposure misclassifi-
cation, because we were unable to measure personal temperature 
exposure, which is associated with people’s daily activities, 
house characteristics and occupational factors. However, a 
previous study using both fixed-site monitoring data and spatial 
models to predict temperature at residence found similar associ-
ations between temperature and mortality.29 Nevertheless, given 
the inherent imprecision of the spatially derived exposure, our 
assessment of exposure was likely subject to non-differential 
misclassification that may have attenuated the estimates.30
cOnclusIOn
Our observation that moderate temperatures were responsible 
for a far greater burden of hospitalisations for CHD and stroke 
than extreme temperatures can have serious global public health 
implications.
Key messages
What is already known on this subject?
Experimental studies show that short-term exposure to ambient 
temperature, especially cold, elevates blood pressure, triggers 
inflammatory reactions and promotes thrombosis, which may 
increase the risk of adverse cardiovascular events. However, little 
is known about the burden of cardiovascular hospitalisations 
related to cold and heat.
What might this study add?
In this study comprising the entire population of Ontario, 
we estimated that exposure to cold and heat, defined as 
temperatures above and below the optimum temperature 
(corresponding to the temperature of minimum morbidity), was 
responsible to 3.7% of coronary heart disease hospitalisations 
and 3.5% of stroke hospitalisations. Importantly, most of 
these excess hospitalisations were attributable to exposure 
to moderate temperatures rather than extreme temperatures, 
defined using cut-offs at the 2.5th and 97.5th temperature 
percentiles.
how might this impact on clinical practice?
Our findings indicate that clinical and public health interventions 
aiming to reduce adverse cardiovascular events could benefit 
from considering cold and heat in both moderate and extreme 
ranges. Advice on preventive behavioural change should be 
given to patients with heart disease and stroke before and 
during cold/hot days.
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